arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Hyperfine, Inc.

HYPR
$0.81 0.00 (-0.15%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
24 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

Hyperfine, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $80.8M
Dividend Yield
Revenue Growth 44.8%
Op. Margin -216.9%
ROIC -16.9%
FCF / Share $-0.07
Trailing P/E
Price / Book 2.2x
FCF Yield
Debt / Equity 0.36
info Valuation on last close. End-of-day price, Sep 23, 2026.

24-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.90M
↑ +44.8%
Net Income Profit after all expenses
$-8.62M
↑ +8.4%
Operating Margin Operating profit as % of sales
-216.9%
↑ +1.1% 0th
FCF / Share Free cash flow per share
$-0.07
↑ +32.3%
Long-Term Debt Long-term obligations
$13.23M
↑ +0.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
1
Returns
11
Cash Quality
55

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 24 quarters